Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

NCT06032000 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Infection
COVID-19 Vaccine Adverse Reaction

Interventions

BIOLOGICAL: LEM-mR203
BIOLOGICAL: Placebo

Sponsor

Lemonex